Blog

Seek truth from facts, competitive symbiosis

scroll down

06

2019-06

Announcement on Changes to the Articles of Association and Registered Capital of Hunan Zhengqing Pharmaceutical Group Co., Ltd.

Hunan Zhengqing Pharmaceutical Group Co., Ltd. (hereinafter referred to as “the Company”) has obtained the approval for the non-public issuance of shares (hereinafter referred to as “this Non-Public Issuance”) to specific investors from the China Securities Regulatory Commission, as per the “Approval on the Non-Public Issuance of Shares by Hunan Zhengqing Pharmaceutical Group Co., Ltd.” (CSRC Approval [2019]2023). The approval permits the Company to non-publicly issue no more than 17,964,071 new shares and brings the Company under the supervision of non-listed public companies. The Company completed this Non-Public Issuance in November 2019, issuing a total of 17,964,071 RMB ordinary shares to 2 specific investors at an issue price of RMB 1.67 per share, raising funds totaling RMB 30,000,000, of which the newly added registered capital (share capital) is RMB 17,964,071. According to the results of this Non-Public Issuance and the authorization by the Company’s Shareholders’ Meeting, the Company has amended relevant articles of the “Articles of Association”. Article 4 of Chapter 1 has been revised to “The Company’s registered capital is RMB 70,270,346”; Article 16 of Chapter 3 has been revised to “The Company’s total share capital is 70,270,346 shares”. The Company has now completed the industrial and commercial registration procedures for the amendment of the “Articles of Association” and the change in registered capital, obtained a new “Business License”, and completed the capital increase registration procedures at Hunan Equity Registration Management Center Co., Ltd. in accordance with relevant regulations. Notice is hereby given. Hunan Zhengqing Pharmaceutical Group Co., Ltd. Board of Directors November 29, 2019